Oncologist shares 10 key facts about neuroendocrine tumours you should know
Dr Vinay Samuel Gaikwad, Head & Director – Surgical Oncology at Fortis Hospital, emphasises that understanding the nuances of neuroendocrine tumours is crucial for improving patient outcomes and treatment efficacy.
Neuroendocrine tumours arise from neuroendocrine cells, which are unique cells that are found throughout the body, particularly in the stomach, intestines, pancreas, and lungs. These cells produce hormones that regulate various functions. When they begin to grow abnormally, they can form tumours, some of which can be slow-growing. In contrast, others may be aggressive, as seen in the Institute for Quality and Efficiency in Health Care (IQWiG).
One of the biggest hurdles with NETs is that they often remain asymptomatic until advanced stages, as per StatPearls. Common symptoms include: Abdominal pain
Diarrhea
Sweating
Unexpected weight loss
Weakness
Skin flushing
These symptoms could easily be mistaken for everyday problems like stress or irritable bowel syndrome, potentially leading to misdiagnosis or delayed treatment.
Many individuals with NETs are diagnosed at later stages due to unclear symptoms. Often, these tumours are identified incidentally during imaging tests done for unrelated conditions. Unfortunately, by that time, the cancer may have already spread, complicating treatment as per Worldwide Cancer Research.
The rising neuroendocrine tumour cases can be linked to two key factors: Advanced screening: Improved diagnostic techniques are enabling healthcare providers to identify NETs more frequently.
Improved diagnostic techniques are enabling healthcare providers to identify NETs more frequently. Lifestyle and environmental factors: Changes in lifestyle and environmental exposures are likely contributing to this increase.
Treatment for NETs depends on various aspects, including: The location of the tumour
Its aggressiveness
Whether it has metastasised (spread) Surgery: Early detection often allows for successful surgical removal.
Early detection often allows for successful surgical removal. Minimally invasive techniques: Laparoscopic and robotic surgeries can reduce recovery time and complications.
Laparoscopic and robotic surgeries can reduce recovery time and complications. Medical treatments: For advanced tumours, treatment may involve targeted medications, hormone therapies, or radiation.
For advanced tumours, treatment may involve targeted medications, hormone therapies, or radiation. Specialised procedures: Techniques such as HIPEC (Hyperthermic Intraperitoneal Chemotherapy) may be utilised in specific situations.
Raising awareness is crucial. Both the public and healthcare professionals need to recognise the signs of NETs early, as catching them in time can lead to significantly better outcomes, according to Dr Vinay, an oncologist.
While the definitive causes of NETs are unclear, certain risk factors can heighten one's risk of developing these tumours: Family history of neuroendocrine cancers
Genetic syndromes, such as Multiple Endocrine Neoplasia (MEN)
Age, as risk increases with age
Managing life with a neuroendocrine tumour presents challenges, as per the journal Oncology and Therapy. Patients are encouraged to: Stay educated about their condition
Maintain open communication with healthcare professionals
Join support groups for emotional and psychological support
Lifestyle choices matter. A balanced diet, regular exercise, and effective stress management techniques can enhance overall health and support the management of neuroendocrine tumours, as per The Nutrition Source.
Promoting awareness about NETs is vital. The more knowledge shared regarding these tumours, the better chances patients have of recognising symptoms early. Advocacy, education, and community outreach can significantly enhance understanding and promote essential testing.
Neuroendocrine tumours may not be the most recognised kinds of cancer, but understanding them is key for early detection and treatment response. If you or someone you know experiences unusual symptoms like chronic stomach issues or sudden weight loss, it may be time to advocate for further testing.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Wire
an hour ago
- The Wire
Successful Completion of First CRS with HIPEC on a 60-year-old Woman with Advanced Peritoneal Carcinomatosis
KOLKATA, India, July 28, 2025 /PRNewswire/ -- In a landmark achievement, a 60-year-old woman with advanced primary peritoneal carcinomatosis was successfully treated with Cytoreductive Surgery (CRS) combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at Manipal Hospital Dhakuria, under the expertise of Dr. Ashutosh Daga, Medical Oncologist, and Dr. Sagnik Ray, Surgical Oncologist. The 12-hour long procedure adds a milestone in cancer care treatment. The sexagenarian was initially taken to another hospital where she was misdiagnosed as a case of chronic liver failure with ascites. When she came to Manipal Hospital Dhakuria, she had trouble breathing and was admitted to the ICU. In the ICU, the fluid in her lungs was drained and chemotherapy was done. Initially, she needed chemotherapy every week but as soon as her condition improvised, she needed it once in three weeks. Subsequently, she was also shifted to the general ward. "We are proud to announce the successful completion of our first CRS with HIPEC at Manipal Hospital Dhakuria—an emerging center for comprehensive cancer care in Kolkata," said Dr. Ashutosh Daga. He went on to add, "Although we have previously performed a lot of CRS procedures and managed numerous advanced malignancies in collaboration with our medical oncologists, this was our first CRS case incorporating HIPEC that paves the way for complex procedures at the hospital for cancer patients." Cytoreductive Surgery (CRS) combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a highly specialized and evolving treatment modality used in the management of select gynecological, gastrointestinal, and occasionally thoracic malignancies. This complex procedure demands surgical precision and seamless coordination across multiple departments—including Anesthesiology, Critical Care, Physical Medicine, and Transfusion Medicine. Dr. Sagnik Ray said, "After 5 months of chemotherapy, she underwent optimal cytoreduction followed by intraoperative delivery of heated chemotherapy using a dedicated HIPEC machine, and she responded to the treatment in a positive manner. The patient had an excellent recovery and was discharged in stable condition on the 9th day of the surgery." About Manipal Hospitals As a pioneer in healthcare, Manipal Hospitals is among the top healthcare providers in India serving over 7 million patients annually. Its focus is to develop an affordable, high-quality healthcare framework through its multispecialty and tertiary care delivery spectrum and further extend it to out-of-hospital care. With the completion of the acquisition of Medica Synergie hospitals and AMRI Hospitals Limited (acquired in Sept 2023), the integrated network today has a pan-India footprint of 37 hospitals across 19 cities with 10,500 beds, a talented pool of 5,600 doctors and an employee strength of over 18,600. Manipal Hospitals provides comprehensive curative and preventive care for a multitude of patients from around the globe. Manipal Hospitals is NABH and AAHRPP accredited, and most of the hospitals in its network are NABL, ER, and Blood Bank accredited and recognized for Nursing Excellence. Manipal Hospitals has also been recognized as the most respected and patient-recommended hospital in India through various consumer surveys. (Disclaimer: The above press release comes to you under an arrangement with PRNewswire and PTI takes no editorial responsibility for the same.). PTI
Business Standard
5 hours ago
- Business Standard
Successful Completion of First CRS with HIPEC on a 60-year-old Woman with Advanced Peritoneal Carcinomatosis
PRNewswire Kolkata (West Bengal) [India], July 28: In a landmark achievement, a 60-year-old woman with advanced primary peritoneal carcinomatosis was successfully treated with Cytoreductive Surgery (CRS) combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at Manipal Hospital Dhakuria, under the expertise of Dr. Ashutosh Daga, Medical Oncologist, and Dr. Sagnik Ray, Surgical Oncologist. The 12-hour long procedure adds a milestone in cancer care treatment. The sexagenarian was initially taken to another hospital where she was misdiagnosed as a case of chronic liver failure with ascites. When she came to Manipal Hospital Dhakuria, she had trouble breathing and was admitted to the ICU. In the ICU, the fluid in her lungs was drained and chemotherapy was done. Initially, she needed chemotherapy every week but as soon as her condition improvised, she needed it once in three weeks. Subsequently, she was also shifted to the general ward. "We are proud to announce the successful completion of our first CRS with HIPEC at Manipal Hospital Dhakuria--an emerging center for comprehensive cancer care in Kolkata," saidDr. Ashutosh Daga. He went on to add, "Although we have previously performed a lot of CRS procedures and managed numerous advanced malignancies in collaboration with our medical oncologists, this was our first CRS case incorporating HIPEC that paves the way for complex procedures at the hospital for cancer patients." Cytoreductive Surgery (CRS) combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a highly specialized and evolving treatment modality used in the management of select gynecological, gastrointestinal, and occasionally thoracic malignancies. This complex procedure demands surgical precision and seamless coordination across multiple departments--including Anesthesiology, Critical Care, Physical Medicine, and Transfusion Medicine. Dr. Sagnik Ray said, "After 5 months of chemotherapy, she underwent optimal cytoreduction followed by intraoperative delivery of heated chemotherapy using a dedicated HIPEC machine, and she responded to the treatment in a positive manner. The patient had an excellent recovery and was discharged in stable condition on the 9th day of the surgery." About Manipal Hospitals As a pioneer in healthcare, Manipal Hospitals is among the top healthcare providers in India serving over 7 million patients annually. Its focus is to develop an affordable, high-quality healthcare framework through its multispecialty and tertiary care delivery spectrum and further extend it to out-of-hospital care. With the completion of the acquisition of Medica Synergie hospitals and AMRI Hospitals Limited (acquired in Sept 2023), the integrated network today has a pan-India footprint of 37 hospitals across 19 cities with 10,500+ beds, a talented pool of 5,600+ doctors and an employee strength of over 18,600. Manipal Hospitals provides comprehensive curative and preventive care for a multitude of patients from around the globe. Manipal Hospitals is NABH and AAHRPP accredited, and most of the hospitals in its network are NABL, ER, and Blood Bank accredited and recognized for Nursing Excellence. Manipal Hospitals has also been recognized as the most respected and patient-recommended hospital in India through various consumer surveys.
Mint
14-07-2025
- Mint
Oncologist shares 10 key facts about neuroendocrine tumours you should know
When we think about cancer, common types like breast, lung, or colon cancer often come to mind. However, Neuroendocrine Tumours (NETs) deserve attention too. Usually overshadowed by more prevalent cancers, NETs are becoming increasingly common, according to the scientific journal Springer. They are frequently diagnosed late due to their vague symptoms, which can be easily mistaken for other health issues. Here are 10 facts about neuroendocrine tumours that everyone should be aware of. Dr Vinay Samuel Gaikwad, Head & Director – Surgical Oncology at Fortis Hospital, emphasises that understanding the nuances of neuroendocrine tumours is crucial for improving patient outcomes and treatment efficacy. Neuroendocrine tumours arise from neuroendocrine cells, which are unique cells that are found throughout the body, particularly in the stomach, intestines, pancreas, and lungs. These cells produce hormones that regulate various functions. When they begin to grow abnormally, they can form tumours, some of which can be slow-growing. In contrast, others may be aggressive, as seen in the Institute for Quality and Efficiency in Health Care (IQWiG). One of the biggest hurdles with NETs is that they often remain asymptomatic until advanced stages, as per StatPearls. Common symptoms include: Abdominal pain Diarrhea Sweating Unexpected weight loss Weakness Skin flushing These symptoms could easily be mistaken for everyday problems like stress or irritable bowel syndrome, potentially leading to misdiagnosis or delayed treatment. Many individuals with NETs are diagnosed at later stages due to unclear symptoms. Often, these tumours are identified incidentally during imaging tests done for unrelated conditions. Unfortunately, by that time, the cancer may have already spread, complicating treatment as per Worldwide Cancer Research. The rising neuroendocrine tumour cases can be linked to two key factors: Advanced screening: Improved diagnostic techniques are enabling healthcare providers to identify NETs more frequently. Improved diagnostic techniques are enabling healthcare providers to identify NETs more frequently. Lifestyle and environmental factors: Changes in lifestyle and environmental exposures are likely contributing to this increase. Treatment for NETs depends on various aspects, including: The location of the tumour Its aggressiveness Whether it has metastasised (spread) Surgery: Early detection often allows for successful surgical removal. Early detection often allows for successful surgical removal. Minimally invasive techniques: Laparoscopic and robotic surgeries can reduce recovery time and complications. Laparoscopic and robotic surgeries can reduce recovery time and complications. Medical treatments: For advanced tumours, treatment may involve targeted medications, hormone therapies, or radiation. For advanced tumours, treatment may involve targeted medications, hormone therapies, or radiation. Specialised procedures: Techniques such as HIPEC (Hyperthermic Intraperitoneal Chemotherapy) may be utilised in specific situations. Raising awareness is crucial. Both the public and healthcare professionals need to recognise the signs of NETs early, as catching them in time can lead to significantly better outcomes, according to Dr Vinay, an oncologist. While the definitive causes of NETs are unclear, certain risk factors can heighten one's risk of developing these tumours: Family history of neuroendocrine cancers Genetic syndromes, such as Multiple Endocrine Neoplasia (MEN) Age, as risk increases with age Managing life with a neuroendocrine tumour presents challenges, as per the journal Oncology and Therapy. Patients are encouraged to: Stay educated about their condition Maintain open communication with healthcare professionals Join support groups for emotional and psychological support Lifestyle choices matter. A balanced diet, regular exercise, and effective stress management techniques can enhance overall health and support the management of neuroendocrine tumours, as per The Nutrition Source. Promoting awareness about NETs is vital. The more knowledge shared regarding these tumours, the better chances patients have of recognising symptoms early. Advocacy, education, and community outreach can significantly enhance understanding and promote essential testing. Neuroendocrine tumours may not be the most recognised kinds of cancer, but understanding them is key for early detection and treatment response. If you or someone you know experiences unusual symptoms like chronic stomach issues or sudden weight loss, it may be time to advocate for further testing.
